A 64-year-old man with cranial-nerve palsies and a positive test for antinuclear cytoplasmic antibodies

New England Journal of Medicine

Volumn 339, Issue 11, 1998, Pages 755-763

  Simms, R W ^a   Kirby, R E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; FACIAL NERVE PARALYSIS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCEPTION DEAFNESS; PRIORITY JOURNAL; TINNITUS; WEGENER GRANULOMATOSIS;

EID: 3543019064     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199809103391108     Document Type: Article

References (50)

1. Nager GT. Pathology of the ear and temporal bone. Baltimore: Williams & Wilkins, 1993:351-62.
2. Plemmons RM, McAllister CK, Liening DA, Garces MC. Otitis media and mastoiditis due to Mycobacterium fortuitum: case report, review of four cases, and a cautionary note. Clin Infect Dis 1996;22:1105-6.
3. Hadfield PJ, Shah BK, Glover GW. Facial palsy due to tuberculosis: the value of the CT. J Laryngol Otol 1995;109:1010-2.
4. Skolnik PR, Nadol JB Jr, Baker AS. Tuberculosis of the middle ear: review of the literature with an instructive case report. Rev Infect Dis 1986; 8:403-10.
5. deShazo RD, Chapin K, Swain RE. Fungal sinusitis. N Engl J Med 1997;337:254-9.
6. Steckelberg JM, McDonald TJ. Otologic involvement in late syphilis. Laryngoscope 1984;94:753-7.
7. Lerner PI. The lumpy jaw: cervicofacial actinomycosis. Infect Dis Clin North Am 1988;2:203-20.
8. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336: 1224-34. [Erratum, N Engl J Med 1997;337:139.]
9. Lieberman PH, Jones CR, Steinman RM, et al. Langerhans cell (eosinophilic) granulomatosis: a clinicopathologic study encompassing 50 years. Am J Surg Pathol 1996;20:519-52.
10. Lunardi P, Farah JO, Qhaso R, Puzzilli F, Siciliano P, Di Stefano D. Primary eosinophilic granuloma invading the skull base: case report and critical review of the literature. Tumori 1996;82:397-400.
11. Goldsmith AJ, Myssiorek D, Valderrama E, Patel M. Unifocal Langerhans' cell histiocytosis (eosinophilic granuloma) of the petrous apex. Arch Otolaryngol Head Neck Surg 1993;119:113-6.
12. Kletzker GR, Smith PG, McIntire LD, Leonetti JP. Presentation and management of uncommon lesions of the middle ear. Am J Otol 1995;16: 634-42.
13. Case Records of the Massachusetts General Hospital (Case 21-1992). N Engl J Med 1992;326:1417-24.
14. Guinee D Jr, Jaffe ES, Kingma D, et al. Pulmonary lymphomatoid granulomatosis: evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am J Surg Pathol 1994;18:753-64.
15. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
16. Andrassy K, Ritz E. Clinical significance of the ANCA test for diagnosis of systemic necrotizing vasculitis: In: Sessa A, Meroni M, Battini G, eds. Renal involvement in systemic vasculitis. Vol. 94 of Contributions to nephrology. Basel, Switzerland: Karger, 1991:22-30.
17. Malnick SD. Testing with antineutrophil cytoplasmic antibody to diagnose Wegener granulomatosis. Ann Intern Med 1996;125:622-3.
18. Allen NB, Bressler PB. Diagnosis and treatment of the systemic and cutaneous necrotizing vasculitis syndromes. Med Clin North Am 1997;81: 243-59.
19. Davenport A, Lock RJ, Wellington TB, Feest TG. Clinical significance of anti-neutrophil cytoplasm antibodies detected by a standardized indirect immunofluoresccnce assay. QJM 1994;87:291-9.
20. Fukase S, Ohta N, Inamura K, Kimura Y, Aoyagi M, Koike Y. Diagnostic specificity of anti-neutrophil cytoplasmic antibodies (ANCA) in otorhinolaryngological diseases. Acta Otolaryngol Suppl (Stockh) 1994; 511:204-7.
21. Edgar JD. The clinical utility of ANCA positivity. Ann Rheum Dis 1996;55:494-6.
22. Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 1997;126:866-73.
23. Kallenberg CM, Mulder AHL, Tervaert JWC. Antineutrophil cytoplasmic antibodies: a still growing class of autoantibodies in inflammatory disorders. Am J Med 1992;93:675-82.
24. van der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;1:425-9.
25. Jennette JC, Falk RJ. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis 1990;15:517-29.
26. Kallenberg CG, Brouwer E, Weening JJ, Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994;46:1-15.
27. Gross WL. Antineutrophil cytoplasmic autoantibody testing in vasculitides. Rheum Dis Clin North Am 1995;21:987-1011.
28. Lhote F, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects and treatment. Rheum Dis Clin North Am 1995;21:911-47.
29. DeRemee RA, Homburger HA, Specks U. Lesions of the respiratory tract associated with the finding of anti-neutrophil cytoplasmic autoantibodies with a perinuclear staining pattern. Mayo Clin Proc 1994;69: 819-24.
30. Topaloglu R, Besbas N, Saatci U, Bakkaloglu A, Oner A. Cranial nerve involvement in childhood polyarteritis nodosa. Clin Neurol Neurosurg 1992;94:11-3.
31. Yoon TH, Paparella MM, Schachern PA. Systemic vasculitis: a temporal bone histopathologic study. Laryngoscope 1989;99:600-9.
32. Cohen P, Guillevin L, Baril L, Lhote F, Noel LH, Lesavre P. Persistence of antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: follow-up of 53 patients. Clin Exp Rheumatol 1995;13:193-8.
33. Leavitt RY, Fauci AS. Polyangiitis overlap syndrome: classification and prospective clinical experience. Am J Med 1986;81:79-85.
34. Newman NJ, Slamovits TL, Friedland S, Wilson WB. Neuro-ophthalmic manifestations of meningocerebral inflammation from the limited form of Wegener's granulomatosis. Am J Ophthalmol 1995;120:613-21.
35. Takano Y, Oida K, Kohri Y, et al. A negative test for antineutrophil cytoplasmic antibody does not necessarily exclude the diagnosis of Wegener's granulomatosis. Intern Med 1996;35:346.
36. Sinico RA, Gregorini G, Radice A, et al. Clinical significance of autoantibodies to myeloperoxidase in vasculitic syndromes. In: Sessa A, Meroni M, Battini G, eds. Renal involvement in systemic vasculitis. Vol. 94 of Contributions to nephrology. Basel, Switzerland: Karger, 1991: 31-7.
37. McDonald TJ, DeRemee RA. Head and neck involvement in Wegener's granulomatosis (WG). Adv Exp Med Biol 1993;336:309-13.
38. Andrews JT, Kountakis SE. Wegener's granulomatosis of the skull base. Am J Otolaryngol 1996;17:349-52.
39. Provenzale JM, Mukherji S, Allen NB, Castillo M, Weber AW. Orbital involvement by Wegener's granulomatosis: imaging findings. AJR Am J Roentgenol 1996;166:929-34.
40. Duna GF, Galperin C, Hoffman GS. Wegener's granulomatosis. Rheum Dis Clin North Am 1995;21:949-86.
41. Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993;33:4-9.
42. Jinnah HA, Dixon A, Brat DJ, Hellman DB. Chronic meningitis with cranial neuropathies in Wegener's granulomatosis: case report and review of the literature. Arthritis Rheum 1997;40:573-7.
43. Kashiyama T, Suzuki A, Mizuguchi K. Wegener's granulomatosis with multiple cranial nerve involvements as the initial clinical manifestations. Intern Med 1995;34:1110-3.
44. Provenzale JM, Allen NB. Wegener granulomatosis: CT and MR findings. AJNR Am J Neuroradiol 1996;17:785-92.
45. Anderson NE, Willoughby EW, Synek BJ. Leptomeningeal and brain biopsy in chronic meningitis. Aust N Z J Med 1995;25:703-6.
46. Wegener F. Wegener's granulomatosis: thoughts and observations of a pathologist. Eur Arch Otorhinolaryngol 1990;247:133-42.
47. Fienberg R. The protracted superficial phenomenon in pathergic (Wegener's) granulomatosis. Hum Pathol 1981;12:458-67.
48. Moore PM. Neurological manifestation of vasculitis: update on immunopathogenic mechanisms and clinical features. Ann Neurol 1995;37:Suppl 1:S131-S141.
49. Hern JD, Hollis LJ, Mochloulis G, Montgomery PQ, Tolley NS. Early diagnosis of Wegener's granulomatosis presenting with facial nerve palsy. J Laryngol Otol 1996;110:459-61.
50. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.